ThermaSolutions Europe BV

The ThermaSolutions ThermoChem™ HT series of devices use hyperthermic technology to assist in cancer treatment during cytoreductive surgery.

From the manufacturer's own website. Source

ThermaSolutions Europe BV manufactures hyperthermic perfusion devices, including the ThermoChem HT-2000 and HurriChem, designed to deliver controlled heat during surgical procedures for cancer treatment. These systems are used alongside cytoreductive surgery to enhance therapeutic effects through localized hyperthermia.

The company’s products fall under EU medical device classes IIa and IIb, are registered in the EU’s eudamed database, and are based in the Netherlands. Compliance with EU Medical Device Regulations governs their authorization and market listing.

Written from this company's registered devices by an AI model, and not verified by a human reviewer.